PROCEPT BioRobotics Corp Files 8-K on Shareholder Votes

TL;DR

PROCEPT BioRobotics filed an 8-K regarding shareholder votes. Check for details on governance.

AI Summary

PROCEPT BioRobotics Corporation filed an 8-K on June 4, 2024, to report on matters submitted to a vote of its security holders. The filing indicates that the company is incorporated in Delaware and its principal executive offices are located at 150 Baytech Drive, San Jose, California.

Why It Matters

This filing is important for investors to understand the governance and voting activities of PROCEPT BioRobotics Corp, which can impact corporate decisions and shareholder rights.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of corporate governance matters and does not inherently present new financial or operational risks.

Key Players & Entities

• PROCEPT BioRobotics Corporation (company) — Registrant
• June 4, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 150 Baytech Drive, San Jose, California 95134 (address) — Principal executive offices
• 001-40797 (filing_id) — Commission File Number

FAQ

Key Financial Figures

• $0.00001 — ge on which registered Common Stock, $0.00001 par value per share PRCT The Nasdaq Sto

Filing Documents

• prct-20240604.htm (8-K) — 36KB
• 0001628280-24-026712.txt ( ) — 156KB
• prct-20240604.xsd (EX-101.SCH) — 2KB
• prct-20240604_lab.xml (EX-101.LAB) — 21KB
• prct-20240604_pre.xml (EX-101.PRE) — 12KB
• prct-20240604_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The annual meeting of stockholders (the "Annual Meeting") of PROCEPT BioRobotics Corporation (the "Company") was held on June 4, 2024. All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2024 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2027 annual meeting of stockholders, or until his or her successor is duly elected or appointed, by the following vote: Name of Nominee Votes For Votes Withheld Broker Non-Votes Amy Dodrill 31,432,304 7,396,713 4,261,507 Taylor Harris 31,484,184 7,344,833 4,261,507 Reza Zadno, Ph.D. 33,361,586 5,467,431 4,261,507 Proposal 2 in the Proxy Statement, a proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024, was approved by the following vote: Votes For Votes Withheld Abstentions 43,015,906 6,635 67,983 Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote: Votes For Votes Withheld Abstentions Broker Non-Votes 37,459,317 1,254,400 115,480 4,261,507

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROCEPT BIOROBOTICS CORPORATION Date: June 4, 2024 By: /s/ Alaleh Nouri Alaleh Nouri EVP, Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR